Journal
EUROPEAN JOURNAL OF IMMUNOLOGY
Volume 46, Issue 12, Pages 2778-2788Publisher
WILEY-BLACKWELL
DOI: 10.1002/eji.201646548
Keywords
CD8(+) T cells; IL-10; IL-27; Influenza; Type I IFN
Categories
Funding
- U.S. National Institutes of Health [AI099753, AI112844, AG047156, AI083024]
- Indiana University Biomedical Research Grant
- American Lung Association Postdoctoral Fellowship Award [RT-310817]
Ask authors/readers for more resources
Recent evidence has suggested that IL-10-producing effector CD8(+) T cells play an important role in regulating excessive inflammation during acute viral infections. However, the cellular and molecular cues regulating the development of IL-10-producing effector CD8(+) T cells are not completely defined. Here, we show that type I interferons (IFNs) are required for the development of IL-10-producing effector CD8(+) T cells during influenza virus infection in mice. We find that type I IFNs can enhance IL-27 production by lung APCs, thereby facilitating IL-10-producing CD8(+) T-cell development through a CD8(+) T-cell-nonautonomous way. Surprisingly, we also demonstrate that direct type I IFN signaling in CD8(+) T cells is required for the maximal generation of IL-10-producing CD8(+) T cells. Type I IFN signaling in CD8(+) T cells, in cooperation with IL-27 and IL-2 signaling, promotes and sustains the expression of IFN regulatory factor 4 (IRF4) and B-lymphocyte-induced maturation protein-1 (Blimp-1), two transcription factors required for the production of IL-10 by effector CD8(+) T cells. Our data reveal a critical role of the innate antiviral effector cytokines in regulating the production of a regulatory cytokine by effector CD8(+) T cells during respiratory virus infection.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available